Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 3
2007 4
2008 1
2009 2
2010 1
2011 1
2012 3
2013 3
2014 6
2015 3
2016 5
2017 6
2018 5
2019 3
2020 8
2021 7
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.
Ooi A. Ooi A. Semin Cancer Biol. 2020 Apr;61:158-166. doi: 10.1016/j.semcancer.2019.10.016. Epub 2019 Nov 2. Semin Cancer Biol. 2020. PMID: 31689495 Free PMC article. Review.
Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is an autosomal dominant hereditary cancer syndrome with incomplete penetrance. ...
Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is an autosomal dominant hereditary cancer
Hereditary leiomyomatosis and renal cell cancer syndrome: An update and review.
Patel VM, Handler MZ, Schwartz RA, Lambert WC. Patel VM, et al. J Am Acad Dermatol. 2017 Jul;77(1):149-158. doi: 10.1016/j.jaad.2017.01.023. Epub 2017 Mar 14. J Am Acad Dermatol. 2017. PMID: 28314682 Review.
Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome is a rare genetic disorder that predisposes individuals to multiple cutaneous leiomyomas, renal cell carcinomas, and in women, uterine leiomyomas. ...
Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome is a rare genetic disorder that p
Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.
Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomäki K, Tomlinson I, Richard S, Linehan WM. Menko FH, et al. Fam Cancer. 2014 Dec;13(4):637-44. doi: 10.1007/s10689-014-9735-2. Fam Cancer. 2014. PMID: 25012257 Free PMC article. Review.
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant condition in which susceptible individuals are at risk for the development of cutaneous leiomyomas, early onset multiple uterine leiomyomas and an aggressive
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant condition in whic
Hereditary Renal Cancer Syndromes.
Yanus GA, Kuligina ES, Imyanitov EN. Yanus GA, et al. Med Sci (Basel). 2024 Feb 18;12(1):12. doi: 10.3390/medsci12010012. Med Sci (Basel). 2024. PMID: 38390862 Free PMC article. Review.
Update on Hereditary Renal Cancer and Imaging Implications.
Walker SM, Gautam R, Turkbey B, Malayeri A, Choyke PL. Walker SM, et al. Radiol Clin North Am. 2020 Sep;58(5):951-963. doi: 10.1016/j.rcl.2020.04.003. Epub 2020 Jun 10. Radiol Clin North Am. 2020. PMID: 32792126 Review.
Hereditary leiomyomatosis and renal cell cancer (HLRCC).
Kiuru M, Launonen V. Kiuru M, et al. Curr Mol Med. 2004 Dec;4(8):869-75. doi: 10.2174/1566524043359638. Curr Mol Med. 2004. PMID: 15579034 Review.
Hereditary leiomyomatosis and renal cell cancer (HLRCC) (MIM 605839) is a recently identified autosomal dominant tumor susceptibility syndrome characterized by predisposition to benign leiomyomas of the skin and the uterus (fibroids, myom
Hereditary leiomyomatosis and renal cell cancer (HLRCC) (MIM 605839) is a recently identified auto
Treatment Strategies for Hereditary Kidney Cancer: Current Recommendations and Updates.
Singh S, Chaurasia A, Gopal N, Malayeri A, Ball MW. Singh S, et al. Discov Med. 2022 Nov-Dec;34(173):205-220. Discov Med. 2022. PMID: 36602871 Free article. Review.
A subset of renal tumors (5-8%) are associated with syndromes such as von Hippel-Lindau (VHL) syndrome, Birt-Hogg-Dube syndrome (BHD), tuberous sclerosis complex (TSC), hereditary papillary renal carcinoma (HPRC), hereditary leiomyomatosis and renal
A subset of renal tumors (5-8%) are associated with syndromes such as von Hippel-Lindau (VHL) syndrome, Birt-Hogg-Dube syndrome (BHD), tuber …
62 results